Dr Rab Prinjha

Rab joined Curve Therapeutics as Chief Research and Development Officer in November 2024, bringing more than 20 years of experience leading discovery programmes and collaborations across immunology, oncology, neuroscience and epigenetics. At GSK, he held senior roles including Head of the Immunology Research Unit and Head of Epigenetics, with teams under his leadership delivering more than 15 clinical candidates and over 30 new targets.

At Curve, Rab guides R&D strategy as the company applies its mammalian cell-based Microcycle discovery platform to difficult intracellular targets in cancer, immunology and inflammation. His work focuses on developing cyclic peptides and macrocycle-derived small molecules as potential therapeutic candidates against challenging targets.